Predictive Value of Serum Heat Shock Protein 90α on the Prognosis of Patients with Lung Adenocarcinoma

References

• Thai AA, Solomon BJ, Sequitur LV, et al. Lung cancer. Lancet. 2021;398(10299):535–554. doi:10.1016/S0140-6736(21)00312-3
   PubMed Web of Science ®Google Scholar
• Lu L, Liu LP, Zhao QQ, et al. Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma. Front Oncol. 2021;11:675545. doi:10.3389/fonc.2021.675545
   PubMed Web of Science ®Google Scholar
• Spella M, Stathopoulos GT. Immune Resistance in Lung Adenocarcinoma. Cancers. 2021;13(3):384. doi:10.3390/cancers13030384
   PubMedGoogle Scholar
• Wu J, Liu T, Rios Z, et al. Heat Shock Proteins and Cancer. Trends Pharmacol Sci. 2017;38(3):226–256. doi:10.1016/j.tips.2016.11.009
   PubMed Web of Science ®Google Scholar
• Li W, Sahu D, Tsen F. Secreted heat shock protein-90 (Hsp90) in wound healing and cancer. Biochim Biophys Acta. 2012;1823(3):730–741. doi:10.1016/j.bbamcr.2011.09.009
   PubMed Web of Science ®Google Scholar
• Hoter A, El-Sabban ME, Naim HY. The HSP90 Family: structure, Regulation, Function, and Implications in Health and Disease. Int J Mol Sci. 2018;19(9):2560. doi:10.3390/ijms19092560
   PubMed Web of Science ®Google Scholar
• Birbo B, Madu EE, Madu CO, et al. Role of HSP90 in Cancer. Int J Mol Sci. 2021;22(19):10317. doi:10.3390/ijms221910317
   PubMed Web of Science ®Google Scholar
• Wang X, Song X, Zhuo W, et al. The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy. Proce National Academy Sci. 2009;106(50):21288–21293. doi:10.1073/pnas.0908151106
   PubMed Web of Science ®Google Scholar
• Cheng Q, Chang JT, Geradts J, et al. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer. Breast Cancer Res. 2012;14(2):R62. doi:10.1186/bcr3168
   PubMed Web of Science ®Google Scholar
• Duus J, Bahar HI, Venkataraman G, et al. Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma. Leuk Lymphoma. 2006;47(7):1369–1378. doi:10.1080/10428190500472123
   PubMed Web of Science ®Google Scholar
• Snigireva AV, Morenkov OS, Skarga YY, et al. A 2,5-Dihydroxybenzoic Acid-Gelatin Conjugate Inhibits the Basal and Hsp90-Stimulated Migration and Invasion of Tumor Cells. J Funct Biomater. 2020;11(2):39. doi:10.3390/jfb11020039
   PubMedGoogle Scholar
• Wang Y, Seyed Barghi SM, Yang Y, Akhavan-Sigari R. Value of HSP90α in Lung Cancer Diagnosis and Recurrence Prediction: a Cohort Study. Oncol Res Treat. 2021;44(11):583–589. doi:10.1159/000519277
   PubMedGoogle Scholar
• Zhou W, Yang Y, Wang Z, et al. Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients. J Healthc Eng. 2021;2021:6929971. doi:10.1155/2021/6929971
   PubMedGoogle Scholar
• Pick E, Kluger Y, Giltnane JM, et al. High HSP90 expression is associated with decreased survival in breast cancer. Cancer Res. 2007;67(7):2932–2937. doi:10.1158/0008-5472.CAN-06-4511
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ni L, Li Q, et al. Diagnostic, clinicopathologic, therapeutic and prognostic value of Plasma Heat Shock Protein 90 levels in patients with advanced Gastrointestinal Carcinoma. J Cancer. 2020;11(20):5890–5899. doi:10.7150/jca.46343
   PubMedGoogle Scholar
• Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol. 2010;11(7):515–528. doi:10.1038/nrm2918
   PubMed Web of Science ®Google Scholar
• Finka A, Goloubinoff P. Proteomic data from human cell cultures refine mechanisms of chaperone-mediated protein homeostasis. Cell Stress Chaperones. 2013;18(10):591–605. doi:10.1007/s12192-013-0413-3
   PubMedGoogle Scholar
• Zhang S, Yu J, Cheng X, et al. Regulation of human Hsp90α gene expression. FEBS Let. 1999;444:130–135. doi:10.1016/S0014-5793(99)00044-7
   PubMedGoogle Scholar
• Rebbe NG, Hickman WS, Ley TJ, et al. Nucleotide sequence and regulation of a human 90-kDa heat shock protein gene. J Biol Chem. 1989;264(25):15006–15011. doi:10.1016/S0021-9258(18)63803-7
   PubMedGoogle Scholar
• Eustace BK, Sakurai T, Stewart JK, et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol. 2004;6(6):507–514. doi:10.1038/ncb1131
   PubMed Web of Science ®Google Scholar
• Ma J, Yang C, Zhong H, et al. Role of HSP90α in osteoclast formation and osteoporosis development. Exp Ther Med. 2022;23(4):273. doi:10.3892/etm.2022.11199
   PubMedGoogle Scholar
• Liao Y, Yang Y, Pan D, et al. HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition under Hypoxia. Cancers. 2021;13(2):243. doi:10.3390/cancers13020243
   PubMedGoogle Scholar
• Tian Y, Wang C, Chen S, et al. Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1. J Cell Sci. 2019;132(15):jcs228213. doi:10.1242/jcs.228213
   PubMedGoogle Scholar
• Xu D, Dong P, Xiong Y, et al. MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1. Cells. 2020;9(3):632. doi:10.3390/cells9030632
   PubMedGoogle Scholar
• Trepel J, Mollapour M, Giaccone G, Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer. 2010;10(8):537–549. doi:10.1038/nrc2887
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ni L, Li Q, et al. Diagnostic, clinicopathologic, therapeutic and prognostic value of Plasma Heat Shock Protein 90 levels in patients with advanced Gastrointestinal Carcinoma. J Cancer. 2020;11(20):5890–5899.
   PubMedGoogle Scholar
• Jameel A, Law M, Coombes R, Luqmani Y. Significance of heat-shock protein-90 as a prognostic indicator in breast-cancer. Int J Oncol. 1993;2(6):1075–1080. doi:10.3892/ijo.2.6.1075
   PubMedGoogle Scholar
• Dimas DT, Perlepe CD, Sergentanis TN, et al. The Prognostic Significance of Hsp70/Hsp90 Expression in Breast Cancer: a Systematic Review and Meta-analysis. Anticancer Res. 2018;38(3):1551–1562. doi:10.21873/anticanres.12384
   PubMedGoogle Scholar
• Chen S, Yu Q, Zhou S. Plasmatic Levels of HSP90α at Diagnosis: a Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy. Front Oncol. 2021;11:765115. doi:10.3389/fonc.2021.765115
   PubMedGoogle Scholar
• Zhang T, Li Q, Zhang Y, Wang Q, Wang H, Gu K. Diagnostic and prognostic value of heat shock protein 90α in malignant melanoma. Melanoma Res. 2021;31(2):152–161. doi:10.1097/CMR.0000000000000716
   PubMedGoogle Scholar
• Li X, Tong X, Liu B, et al. Potential predictive value of plasma heat shock protein 90α in lung cancer. J Int Med Res. 2021;49(12):3000605211064393. doi:10.1177/03000605211064393
   Google Scholar
• Bar JK, Cierpikowski P, Lis-Nawara A, et al. Comparison of p53, HSP90, E-cadherin and HPV in oral lichen planus and oral squamous cell carcinoma. Acta Otorhinolaryngol Ital. 2021;41(6):514–522. doi:10.14639/0392-100X-N1450
   PubMedGoogle Scholar
• Usman M, Ilyas A, Syed B, et al. Serum HSP90-Alpha and Oral Squamous Cell Carcinoma: a Prospective Biomarker. Protein Pept Lett. 2021;28(10):1157–1163. doi:10.2174/0929866528666210616112539
   PubMedGoogle Scholar
• Zhai E, Liang W, Lin Y, et al. HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer. Cell Physiol Biochem. 2018;47(2):879–892. doi:10.1159/000490080
   PubMedGoogle Scholar
• Liu K, Xu SH, Chen Z, et al. TRPM7 overexpression enhances the cancer stem cell-like and metastatic phenotypes of lung cancer through modulation of the Hsp90α/uPA/MMP2 signaling pathway. BMC Cancer. 2018;18(1):1167. doi:10.1186/s12885-018-5050-x
   PubMedGoogle Scholar
• Wang Q, Sun W, Hao X, et al. Down-regulation of cellular FLICE-inhibitory protein (Long Form) contributes to apoptosis induced by Hsp90 inhibition in human lung cancer cells. Cancer Cell Int. 2012;12(1):54. doi:10.1186/1475-2867-12-54
   PubMedGoogle Scholar
• Watanabe S, Goto Y, Yasuda H, et al. HSP90 inhibition overcomes EGFR amplification-induced resistance to third-generation EGFR-TKIs. Thorac Cancer. 2021;12(5):631–642. doi:10.1111/1759-7714.13839
   PubMedGoogle Scholar
• Sang J, Acquaviva J, Friedland JC, et al. Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancer. Cancer Discov. 2013;(4):430–443. doi:10.1158/2159-8290.CD-12-0440
   PubMedGoogle Scholar
• Holdenrieder S, Wehnl B, Hettwer K, et al. Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis. Br J Cancer. 2017;116(8):1037–1045. doi:10.1038/bjc.2017.45
   PubMedGoogle Scholar
• Dal Bello MG, Filiberti RA, et al. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. J Transl Med. 2019;17(1):74. doi:10.1186/s12967-019-1828-0
   PubMedGoogle Scholar
• Shi Y, Liu X, Lou J, et al. Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responses. Clin Cancer Res. 2014;20(23):6016. doi:10.1158/1078-0432.CCR-14-0174
   PubMed Web of Science ®Google Scholar